Migraine Models

Charles River conducts contract studies in trigeminal ganglia electrostimulation and cortical spreading depression (KCl-induced) animal models to assess the efficacy of novel antimigraine drugs. The electrical stimulation of the trigeminal ganglion induces changes in cerebral blood flow (CBF) observed in migraine as well as changes in plasma protein extravasation and levels of CGRP. The chemical induction of cortical spreading depression by application of KCl also induces changes in CBF as well as changes in direct current potential and CGRP release.

Testing / Validation Data

Click below to see a sample data set.

You may also be interested in...

Biomarker Services

We can support your drug discovery pipeline by providing biomarker analysis in a non-GxP environment.

small animal imaging

Imaging Services

Our range of imaging modalities can dramatically increase the efficiency and significantly enhance the value of your in vivo study.